These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 34108112)

  • 21. Early identification of peripheral neuropathy based on sudomotor dysfunction in Mexican patients with type 2 diabetes.
    Carbajal-Ramírez A; Hernández-Domínguez JA; Molina-Ayala MA; Rojas-Uribe MM; Chávez-Negrete A
    BMC Neurol; 2019 May; 19(1):109. PubMed ID: 31151430
    [TBL] [Abstract][Full Text] [Related]  

  • 22. One-stop microvascular screening service: an effective model for the early detection of diabetic peripheral neuropathy and the high-risk foot.
    Binns-Hall O; Selvarajah D; Sanger D; Walker J; Scott A; Tesfaye S
    Diabet Med; 2018 Jul; 35(7):887-894. PubMed ID: 29608799
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Sweat function evaluation for early diagnosis of diabetic peripheral neuropathy].
    Shen J; Cao Y; Han YJ; Luo XR; Xie CH; Li JM; Xue YM
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Aug; 27(8):1210-2. PubMed ID: 17715028
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plantar pressure distribution in Type 2 diabetic patients without peripheral neuropathy and peripheral vascular disease.
    Pataky Z; Assal JP; Conne P; Vuagnat H; Golay A
    Diabet Med; 2005 Jun; 22(6):762-7. PubMed ID: 15910629
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of Sudoscan feet asymmetry in the diabetic foot.
    Gatev T; Gateva A; Assyov Y; Nacheva S; Petrova J; Poromanski I; Kamenov Z
    Prim Care Diabetes; 2020 Feb; 14(1):47-52. PubMed ID: 31153799
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Morphofunctional characteristics of the foot in patients with diabetes mellitus and diabetic neuropathy.
    García-Álvarez Y; Lázaro-Martínez JL; García-Morales E; Cecilia-Matilla A; Aragón-Sánchez J; Carabantes-Alarcón D
    Diabetes Metab Syndr; 2013; 7(2):78-82. PubMed ID: 23680245
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of the Neuropad sudomotor function test as a screening tool for polyneuropathy in the elderly population with diabetes and pre-diabetes: the KORA F4 survey.
    Ziegler D; Papanas N; Rathmann W; Heier M; Scheer M; Meisinger C;
    Diabetes Metab Res Rev; 2012 Nov; 28(8):692-7. PubMed ID: 22949335
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationship of limited joint mobility and foot deformities with neurological examination in patients with diabetes.
    Sanz-Corbalán I; Lázaro-Martínez JL; García-Morales E; Aragón-Sánchez J; Carabantes-Alarcón D; García-Álvarez Y
    Exp Clin Endocrinol Diabetes; 2013 Apr; 121(4):239-43. PubMed ID: 23329582
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Accuracy of the Neuropad test for the diagnosis of distal symmetric polyneuropathy in type 2 diabetes.
    Papanas N; Paschos P; Papazoglou D; Papatheodorou K; Paletas K; Maltezos E; Tsapas A
    Diabetes Care; 2011 Jun; 34(6):1378-82. PubMed ID: 21505209
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hidden dangers revealed by misdiagnosed diabetic neuropathy: A comparison of simple clinical tests for the screening of vibration perception threshold at primary care level.
    Azzopardi K; Gatt A; Chockalingam N; Formosa C
    Prim Care Diabetes; 2018 Apr; 12(2):111-115. PubMed ID: 29029862
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of peripheral arterial occlusive disease on the Neuropad(®) test performance in patients with diabetes.
    Aubert CE; Le Doeuff J; Lajou J; Barthelemy O; Hartemann A; Bourron O
    Diabet Med; 2013 May; 30(5):e178-84. PubMed ID: 23398465
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Predictors for diabetic neuropathy according to applied criteria of its diagnosis].
    Gryz EA; Szermer P; Galicka-Latała D; Sieradzki J; Szczudlik A
    Przegl Lek; 2002; 59(11):881-4. PubMed ID: 12715713
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diabetic Peripheral Neuropathy in Ethiopia: A Systematic Review and Meta-Analysis.
    Tadesse DB; Gebrewahd GT; Hailay A; Aberhe W; Mebrahtom G; Zereabruk K; Gebreayezgi G; Mariye T; Haile TG; Gebremeskel GG; Demoz GT
    J Diabetes Res; 2021; 2021():5304124. PubMed ID: 33628833
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuropad as a diagnostic tool for diabetic autonomic and sensorimotor neuropathy.
    Spallone V; Morganti R; Siampli M; Fedele T; D'Amato C; Cacciotti L; Maiello MR
    Diabet Med; 2009 Jul; 26(7):686-92. PubMed ID: 19573117
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reproducibility of the new indicator test for sudomotor function (Neuropad) in patients with type 2 diabetes mellitus: short communication.
    Papanas N; Papatheodorou K; Papazoglou D; Christakidis D; Monastiriotis C; Maltezos E
    Exp Clin Endocrinol Diabetes; 2005 Dec; 113(10):577-81. PubMed ID: 16320155
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical correlates of sudomotor dysfunction in patients with type 2 diabetes and peripheral neuropathy.
    Shivaprasad C; Amit G; Anish K; Rakesh B; Anupam B; Aiswarya Y
    Diabetes Res Clin Pract; 2018 May; 139():188-194. PubMed ID: 29524484
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of small fiber neuropathy through a quick, simple and non invasive method in a German diabetes outpatient clinic.
    Calvet JH; Dupin J; Winiecki H; Schwarz PE
    Exp Clin Endocrinol Diabetes; 2013 Feb; 121(2):80-3. PubMed ID: 23073917
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adherence to a Healthy Lifestyle in Association With Microvascular Complications Among Adults With Type 2 Diabetes.
    Liu G; Li Y; Pan A; Hu Y; Chen S; Qian F; Rimm EB; Manson JE; Stampfer MJ; Giatsidis G; Sun Q
    JAMA Netw Open; 2023 Jan; 6(1):e2252239. PubMed ID: 36701156
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cost-effectiveness analysis of the Neuropad device as a screening tool for early diabetic peripheral neuropathy.
    Rodríguez-Sánchez B; Peña-Longobardo LM; Sinclair AJ
    Eur J Health Econ; 2020 Apr; 21(3):335-349. PubMed ID: 31720872
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of the self-administered indicator plaster neuropad for the diagnosis of neuropathy in diabetes.
    Tentolouris N; Achtsidis V; Marinou K; Katsilambros N
    Diabetes Care; 2008 Feb; 31(2):236-7. PubMed ID: 18025406
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.